Cancer Stem Cells and Stemness: Potential Clinical Implications in Gastrointestinal Cancers

Manish A. Shah, MD, reviews the central role of cancer stem cells in GI cancer tumorigenesis, relapse, and metastasis and assesses emerging clinical data for novel cancer stem cell–targeted therapies in the treatment of patients with gastric, colorectal, and pancreatic cancers.
Manish A. Shah, MD

ClinicalThought

Here’s my take on recent developments in cancer stem cell inhibitors for gastrointestinal cancers, including new data from ASCO 2018.

Manish A. Shah, MD Released: June 28, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an educational grant from
Boston Biomedical, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue